Literature DB >> 19427510

The functional effect of pathogenic mutations in Rab escort protein 1.

Y V Sergeev1, N Smaoui, R Sui, D Stiles, N Gordiyenko, N Strunnikova, I M Macdonald.   

Abstract

Choroideremia (CHM) is a chorioretinal degeneration with an X-linked pattern of inheritance. Affected males experience progressive atrophy of the choroid, retinal pigment epithelium and retina leading to eventual blindness. The CHM gene encodes Rab escort protein 1 (REP-1). REP-1 is involved in trafficking of Rab proteins in the cell. To date, the majority of reported mutations in the CHM gene cause a complete loss of REP-1 function. Here we report pathogenic mutations: a novel missense mutation, L550P; a truncation c.1542T>A, STOP; and two deletions (c.525_526delAG and c.1646delC) in the CHM gene and their phenotypic effect. To analyze the effect of mutations, the 3D structure of human REP-1 and the proteins associated with REP-1 function were modeled using sequence homology with rat proteins. In silico analysis of the missense mutation L550P suggests that the proline residue at position 550 destabilizes the beta-structural elements, and the REP-1 tertiary structure. Truncation and deletion mutants are associated with a partial or total loss of the REP-1 essential activity and protein-protein interactions as predicted by the analysis of the structure and stability of these protein products. The presumptive loss of protein was confirmed by Western Blot analysis of protein from mononuclear cells and fibroblasts (FB) from CHM patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19427510      PMCID: PMC2680797          DOI: 10.1016/j.mrfmmm.2009.02.015

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  29 in total

Review 1.  Rab proteins as membrane organizers.

Authors:  M Zerial; H McBride
Journal:  Nat Rev Mol Cell Biol       Date:  2001-02       Impact factor: 94.444

2.  Structure of Rab escort protein-1 in complex with Rab geranylgeranyltransferase.

Authors:  Olena Pylypenko; Alexey Rak; Reinhard Reents; Anca Niculae; Vadim Sidorovitch; Maria Daniela Cioaca; Ekaterina Bessolitsyna; Nicolas H Thomä; Herbert Waldmann; Ilme Schlichting; Roger S Goody; Kirill Alexandrov
Journal:  Mol Cell       Date:  2003-02       Impact factor: 17.970

Review 3.  Protein degradation and protection against misfolded or damaged proteins.

Authors:  Alfred L Goldberg
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

4.  A structural model of the GDP dissociation inhibitor rab membrane extraction mechanism.

Authors:  Alexander Ignatev; Sergey Kravchenko; Alexey Rak; Roger S Goody; Olena Pylypenko
Journal:  J Biol Chem       Date:  2008-04-20       Impact factor: 5.157

5.  Prediction of protein side-chain conformation by packing optimization.

Authors:  C Lee; S Subbiah
Journal:  J Mol Biol       Date:  1991-01-20       Impact factor: 5.469

6.  A general method applicable to the search for similarities in the amino acid sequence of two proteins.

Authors:  S B Needleman; C D Wunsch
Journal:  J Mol Biol       Date:  1970-03       Impact factor: 5.469

7.  Electroretinographic findings in selected pedigrees with choroideremia.

Authors:  P A Sieving; J H Niffenegger; E L Berson
Journal:  Am J Ophthalmol       Date:  1986-03-15       Impact factor: 5.258

8.  Conformational preferences of amino acids in globular proteins.

Authors:  M Levitt
Journal:  Biochemistry       Date:  1978-10-03       Impact factor: 3.162

Review 9.  Choroideremia gene testing.

Authors:  Ian M MacDonald; Christina Sereda; Kerry McTaggart; Dean Mah
Journal:  Expert Rev Mol Diagn       Date:  2004-07       Impact factor: 5.225

10.  Structure of the Rab7:REP-1 complex: insights into the mechanism of Rab prenylation and choroideremia disease.

Authors:  Alexey Rak; Olena Pylypenko; Anca Niculae; Konstantin Pyatkov; Roger S Goody; Kirill Alexandrov
Journal:  Cell       Date:  2004-06-11       Impact factor: 41.582

View more
  24 in total

1.  Clinical utility gene card for: choroideremia.

Authors:  Mariya Moosajee; Simon C Ramsden; Graeme C M Black; Miguel C Seabra; Andrew R Webster
Journal:  Eur J Hum Genet       Date:  2013-08-21       Impact factor: 4.246

Review 2.  A comprehensive review of retinal gene therapy.

Authors:  Shannon E Boye; Sanford L Boye; Alfred S Lewin; William W Hauswirth
Journal:  Mol Ther       Date:  2013-01-29       Impact factor: 11.454

3.  Natural History of the Central Structural Abnormalities in Choroideremia: A Prospective Cross-Sectional Study.

Authors:  Tomas S Aleman; Grace Han; Leona W Serrano; Nicole M Fuerst; Emily S Charlson; Denise J Pearson; Daniel C Chung; Anastasia Traband; Wei Pan; Gui-Shuang Ying; Jean Bennett; Albert M Maguire; Jessica I W Morgan
Journal:  Ophthalmology       Date:  2016-12-13       Impact factor: 12.079

4.  Molecular Therapy for Choroideremia: Pre-clinical and Clinical Progress to Date.

Authors:  Vasiliki Kalatzis; Anne-Françoise Roux; Isabelle Meunier
Journal:  Mol Diagn Ther       Date:  2021-10-18       Impact factor: 4.074

5.  Loss-of-function mutations in Rab escort protein 1 (REP-1) affect intracellular transport in fibroblasts and monocytes of choroideremia patients.

Authors:  Natalia V Strunnikova; Jennifer Barb; Yuri V Sergeev; Ashwin Thiagarajasubramanian; Christopher Silvin; Peter J Munson; Ian M Macdonald
Journal:  PLoS One       Date:  2009-12-22       Impact factor: 3.240

6.  Clinical characteristics of a large choroideremia pedigree carrying a novel CHM mutation.

Authors:  Alex S Huang; Leo A Kim; Amani A Fawzi
Journal:  Arch Ophthalmol       Date:  2012-09

7.  Silencing of the CHM gene alters phagocytic and secretory pathways in the retinal pigment epithelium.

Authors:  Nataliya V Gordiyenko; Robert N Fariss; Connie Zhi; Ian M MacDonald
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-09-09       Impact factor: 4.799

8.  Genetic and phenotypic characteristics of three Mainland Chinese families with choroideremia.

Authors:  Qi Zhou; Liang Liu; Fei Xu; Hui Li; Yuri Sergeev; Fangtian Dong; Ruxin Jiang; Ian MacDonald; Ruifang Sui
Journal:  Mol Vis       Date:  2012-02-03       Impact factor: 2.367

9.  Pathogenic mechanisms and the prospect of gene therapy for choroideremia.

Authors:  Ioannis S Dimopoulos; Stephanie Chan; Robert E MacLaren; Ian M MacDonald
Journal:  Expert Opin Orphan Drugs       Date:  2015-07-01       Impact factor: 0.694

10.  AAV-mediated gene therapy for choroideremia: preclinical studies in personalized models.

Authors:  Vidyullatha Vasireddy; Jason A Mills; Rajashekhar Gaddameedi; Etiena Basner-Tschakarjan; Monika Kohnke; Aaron D Black; Krill Alexandrov; Shangzhen Zhou; Albert M Maguire; Daniel C Chung; Helen Mac; Lisa Sullivan; Paul Gadue; Jeannette L Bennicelli; Deborah L French; Jean Bennett
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.